Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-cash Items (2019 - 2023)

ADC Therapeutics has reported Non-cash Items over the past 5 years, most recently at -$113285.0 for Q3 2023.

  • Quarterly results put Non-cash Items at -$113285.0 for Q3 2023, down 58.53% from a year ago — trailing twelve months through Sep 2023 was -$113285.0 (down 58.53% YoY), and the annual figure for FY2022 was -$71082.0, up 66.44%.
  • Non-cash Items reached -$113285.0 in Q3 2023 per ADCT's latest filing, down from -$79786.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at -$29372.0 in Q1 2022 and bottomed at -$39.4 million in Q1 2020.
  • Median Non-cash Items over the past 5 years was -$99208.0 (2022), compared with a mean of -$2.6 million.
  • The largest annual shift saw Non-cash Items soared 99.86% in 2021 before it plummeted 58.53% in 2023.
  • Over 5 years, Non-cash Items stood at -$114745.0 in 2019, then plummeted by 57.51% to -$180734.0 in 2020, then dropped by 17.18% to -$211785.0 in 2021, then surged by 66.44% to -$71082.0 in 2022, then plummeted by 59.37% to -$113285.0 in 2023.
  • Business Quant data shows Non-cash Items for ADCT at -$113285.0 in Q3 2023, -$79786.0 in Q2 2023, and -$42277.0 in Q1 2023.